To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
NCT03752099
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
80
Enrollment
INDUSTRY
Sponsor class
Stopped
Administrative decision
Conditions
Metastatic Castration Resistant Prostate Cancer
Interventions
DRUG:
VERU-111
Sponsor
Veru Inc.